The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
Man lost 54 Kgs in 6 months with MGB procedure
Subscribe To Our Newsletter & Stay Updated
